Press release - 27/09/2018 Three new Clusters of Excellence for Tübingen University takes next hurdle in the German government’s Excellence Strategy funding program. The University of Tübingen is to have three new Clusters of Excellence.As part of the German government’s Excellence Strategy funding forhigher education research, Tübingen will host new outstanding research networks starting in January 2019. Representatives of Germany’s higher education policymakers announced the decision in Bonn on Thursday.https://www.gesundheitsindustrie-bw.de/en/article/press-release/three-new-clusters-of-excellence-for-tuebingen
Dossier - 28/08/2018 With molecular diagnostics to biomarker-based personalised therapy Diagnosing suitable biomarkers is a prerequisite for tailoring personalised therapies to patient heterogeneity. Genetic tests and genome sequencing play a key role in these diagnoses. Up until now, personalised therapy has achieved the greatest success in the field of oncology. However, personalised treatments are also gaining in importance for treating other diseases.https://www.gesundheitsindustrie-bw.de/en/article/dossier/with-molecular-diagnostics-to-biomarker-based-personalised-therapy
Expert interview - 08/08/2018 Ludolph: diagnosing and treating neurodegenerative disorders Ulm has long been a world leader in diagnosing and treating rare neurological disorders, notably amyotrophic lateral sclerosis (ALS), frontotemporal dementia (FTD) and Huntington's disease (HD). We spoke with Professor Albert C. Ludolph, spokesperson for the Ulm DZNE site, medical director of the Clinic for Neurology at the RKU (University and Rehabilitation Clinics of Ulm) and world-renowned ALS researcher.https://www.gesundheitsindustrie-bw.de/en/article/news/ludolph-diagnosing-and-treating-neurodegenerative-disorders
Press release - 21/02/2018 German Cancer Award for Michael Baumann Michael Baumann, Chairman and Scientific Director of the German Cancer Research Center (DKFZ) in Heidelberg, receives the 2017 German Cancer Award in the category "Translational Research". The science award, which is sponsored by the German Cancer Society and the German Cancer Foundation, is one of the most prestigious distinctions in cancer medicine in Germany.https://www.gesundheitsindustrie-bw.de/en/article/press-release/german-cancer-award-for-michael-baumann
Press release - 01/12/2017 Berlin-Brandenburg Academy Prize for Lena Maier-Hein Lena Maier-Hein from the German Cancer Research Center (DKFZ) helps physicians get better vision during minimally-invasive surgery. Using novel methods of image analysis, she wants to provide additional image information for surgeons. Thus, they can better differentiate tumors from healthy tissue and execute safer surgical tumor therapies. Maier-Hein now receives the Prize of the Berlin-Brandenburg Academy of Sciences and Humanities, which is…https://www.gesundheitsindustrie-bw.de/en/article/press-release/berlin-brandenburg-academy-prize-for-lena-maier-hein
Press release - 05/09/2017 Cell marking opens up a window into the body A new and particularly reliable method for marking cells can simplify research into diseases such as myocardial infarction, diabetes or Alzheimer's and reduce the use of test animals: Scientists from the University of Tübingen have developed a method by which they can target specific cell types in mice and monitor their behavior using positron emission tomography (PET). PET-based cell tracking allows scientists to observe complex life…https://www.gesundheitsindustrie-bw.de/en/article/press-release/cell-marking-opens-up-a-window-into-the-body
Press release - 22/06/2017 MRI without contrast agents? Yes, with sugar! Scientists from the German Cancer Research Center (DKFZ), in collaboration with colleagues from Heidelberg University Hospital, have been able to visualize brain cancer using a novel MRI method. They use a simple sugar solution instead of conventional contrast agents, which can have side effects in the body.https://www.gesundheitsindustrie-bw.de/en/article/press-release/mri-without-contrast-agents-yes-with-sugar
Article - 12/04/2017 Imaging flow cytometry – introducing a new era of imaging High-resolution images or quantifiable results? Up until now, researchers usually had to choose. All this has now changed thanks to a single device known as an imaging flow cytometer that combines fluorescence microscopy and flow cytometry. The new device gives new insights into complex biological phenomena in cells. It is available for research purposes at the Research Centre for Women’s Health at the University Hospital of Tübingen, which…https://www.gesundheitsindustrie-bw.de/en/article/news/imaging-flow-cytometry-introducing-a-new-era-of-imaging
Press release - 31/01/2017 Background Suppression for Super-resolution Light Microscopy Researchers of Karlsruhe Institute of Technology (KIT) have developed a new fluorescence microscopy method: STEDD (Stimulation Emission Double Depletion) nanoscopy produces images of highest resolution with suppressed background. The new method yields an enhanced image quality, which is advantageous when analyzing three-dimensional, densely arranged subcellular structures. STEDD, a further development of the STED method, is now presented in…https://www.gesundheitsindustrie-bw.de/en/article/press-release/background-suppression-for-super-resolution-light-microscopy
Imaging Methods - 03/11/2016 Using sugar to detect brain tumours An international team of researchers is developing an MRI-based method for the early detection of human brain tumours. The method is called CEST-MRI and it detects elevated glucose concentrations in humour tissues, quantitatively and at high spatial resolution. It does not expose patients to radiation, is non-invasive and relatively inexpensive. https://www.gesundheitsindustrie-bw.de/en/article/news/using-sugar-to-detect-brain-tumours
Company profile - 18/07/2016 mbits imaging GmbH – mobile app in the field of radiology Trying to get a second opinion from a medical colleague who is at home preparing dinner may be quite a challenge, especially when the colleague does not have access to the necessary image data. This has now become easier in the field of radiology thanks to a mobile app called mRay, which provides a reliable way for radiologists to share medical images on mobile devices. https://www.gesundheitsindustrie-bw.de/en/article/news/mbits-imaging-gmbh-mobile-app-in-the-field-of-radiology
Article - 23/05/2016 Fungal infections of the lungs – antibody-based imaging improves diagnosis Cancer was the first area of diagnostics in which antibody-based PET/MRI imaging was used. The diagnosis of fungal infections will be the next. The innovative method is being developed by a European research consortium coordinated by researchers in Tübingen. https://www.gesundheitsindustrie-bw.de/en/article/news/fungal-infections-of-the-lungs-antibody-based-imaging-improves-diagnosis
Medical technology - 14/03/2016 The operating room of the future: minimally invasive and future-oriented intervention techniques Being able to diagnose and treat tumour patients in just a few hours is just one of the many promising goals of the Fraunhofer Project Group for Automation in Medicine and Biotechnology (PAMB). The overall goal of the Intervention and Therapy research group is to take innovative technologies for diagnostic and therapeutic interventions from laboratory development to prototype production for use in clinical trials.https://www.gesundheitsindustrie-bw.de/en/article/news/the-operating-room-of-the-future-minimally-invasive-and-future-oriented-intervention-techniques
Article - 21/12/2015 Using a heart simulator for optimal therapy A realistic computer model of the human heart is expected to make treating heart diseases more effective: doctors will be able to test medicines and surgical techniques on the computer heart and determine the most effective therapy. Olaf Dössel, director of the Institute of Biomedical Engineering at the Karlsruhe Institute of Technology, believes that his team's heart model is among the top five in the world.https://www.gesundheitsindustrie-bw.de/en/article/news/using-a-heart-simulator-for-optimal-therapy
Article - 03/09/2015 Pattern formation: How undifferentiated cell clusters develop orderly structures Dr. Patrick Müller explores cellular signalling pathways that turn undifferentiated cell clusters into orderly structures as embryos develop. Supported by an ERC grant, the Max Planck researcher from Tübingen uses a broad range of methods from the fields of genetics, biophysics, mathematics and the computer sciences for his investigations. Regenerative medicine is one field that particularly stands to benefit from Müller’s findings. https://www.gesundheitsindustrie-bw.de/en/article/news/pattern-formation-how-undifferentiated-cell-clusters-develop-orderly-structures
Article - 22/06/2015 Attentive observer of metabolic processes Physicist Dr. Jan-Bernd Hövener makes magnetic resonance imaging devices smaller and their magnetic fields weaker in the hope that precisely these properties will help him detect abnormal metabolic processes and tumours. On 9th June 2015, the International Organisation for Medical Physics (IOMP) awarded Hövener the Young Scientist Award in Medical Physics, the organisation’s most important prize for up-and-coming scientists. https://www.gesundheitsindustrie-bw.de/en/article/news/attentive-observer-of-metabolic-processes
Overview Diagnostics The latest articles, press releases and dossiers on diagnostics in Baden-Württemberghttps://www.gesundheitsindustrie-bw.de/en/article/diagnostics
Overview Medical technology The latest articles, press releases and dossiers on medical technology in Baden-Württemberghttps://www.gesundheitsindustrie-bw.de/en/article/medtech
Article - 20/10/2014 Michael Schindler: HI virus and host interactions Prof. Dr. Michael Schindler explores the interaction between viruses and their human host cells on the molecular level. His specific interest is HI virus infections and the mechanisms the virus uses to attack the human immune system. Schindler’s eventual aim is to identify a new target for the therapy of HIV infections. In April 2014, Schindler was appointed head of the Department of Molecular Virology of Human Infectious Diseases at the…https://www.gesundheitsindustrie-bw.de/en/article/news/michael-schindler-hi-virus-and-host-interactions
Press release - 09/10/2014 Stefan Hell - Nobel Prize in Chemistry For the second time a researcher at the DKFZ has been awarded the highest distinction in science: Professor Stefan Hell, director of the Max-Planck Institute for Biophysical Chemistry in Göttingen and department head at the DKFZ, has been awarded this year´s Nobel Prize in Chemistry for his pioneering work in the field of ultra high resolution fluorescence microscopy. This follows the 2008 Nobel Prize in Medicine for Harald zur Hausen.https://www.gesundheitsindustrie-bw.de/en/article/press-release/stefan-hell-nobel-prize-in-chemistry
Article - 07/04/2014 BIPSO GmbH – modern contrast agents for the entire world BIPSO GmbH, based in Singen, Germany, has been manufacturing contrast agents for applications in modern medical diagnostics since 2011. BIPSO is part of the Bracco Imaging Group, which is one of the world’s leading specialists in the diagnostic imaging business, and produces imaging agents mainly for Bracco’s sales organisations. The company has recently invested in the expansion of its manufacturing site in Singen with the goal of consolidating…https://www.gesundheitsindustrie-bw.de/en/article/news/bipso-gmbh-modern-contrast-agents-for-the-entire-world
Article - 22/07/2013 Marcus Fändrich strengthens protein biochemistry at Ulm University After quite a long vacancy the directors post of the Institute for Pharmaceutical Biotechnology at the University of Ulm has finally been filled. Marcus Fändrich and his team moved into the laboratories and offices of the new life sciences building on the Oberer Eselsberg Ulm University campus in November 2012. Fändrich fills a gap in the Ulm Bioregions biopharmaceutical education activities as he will not only be teaching biochemistry…https://www.gesundheitsindustrie-bw.de/en/article/news/marcus-faendrich-strengthens-protein-biochemistry-at-ulm-university
Press release - 26/11/2012 Functional Magnetic Resonance Imaging under the Magnifying Glass Jozien Goense from the Max Planck Institute for Biological Cybernetics in Tübingen Germany and her colleagues used functional Magnetic Resonance Imaging fMRI to observe these layer-specific neural processes within the cortex and found different mechanisms for fMRI response increases and decreases as well as cortical layer-dependent differences in the neurovascular coupling mechanism. https://www.gesundheitsindustrie-bw.de/en/article/press-release/functional-magnetic-resonance-imaging-under-the-magnifying-glass